Cargando…
Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic
Background: The main objective of this research was to analyze whether there were changes in the use of antidepressants, anxiolytics, and hypnotic-sedative drugs, in the context of primary health care, during the COVID-19 pandemic compared to the pre-pandemic period. We further sought to study consu...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030027/ https://www.ncbi.nlm.nih.gov/pubmed/35457647 http://dx.doi.org/10.3390/ijerph19084782 |
_version_ | 1784692043860148224 |
---|---|
author | González-López, María del Carmen Díaz-Calvo, Virginia Ruíz-González, Carlos Nievas-Soriano, Bruno José Rebollo-Lavado, Belén Parrón-Carreño, Tesifón |
author_facet | González-López, María del Carmen Díaz-Calvo, Virginia Ruíz-González, Carlos Nievas-Soriano, Bruno José Rebollo-Lavado, Belén Parrón-Carreño, Tesifón |
author_sort | González-López, María del Carmen |
collection | PubMed |
description | Background: The main objective of this research was to analyze whether there were changes in the use of antidepressants, anxiolytics, and hypnotic-sedative drugs, in the context of primary health care, during the COVID-19 pandemic compared to the pre-pandemic period. We further sought to study consumption in vulnerable population groups. Methods: A cross-sectional observational study was performed in a primary health district of Spain. The data were obtained from the Andalusian Public Health System database, for the pre-COVID-19 period, from March 2019 to February 2020, and for the COVID-19 period, from March 2020 to February 2021. Univariant and bivariant analyses were performed. The effect size was measured using the Rosenthal test. Results: While the total number of medical prescriptions decreased by 2.5% in the COVID-19 period, the prescriptions of psychiatric drugs increased by 6.1%. The increase in the dose consumption per 1000 inhabitants (DHD) was highest for anxiolytics (7.2%), followed by hypnotic-sedatives (5.6%) and antidepressants (3.7%). The consumption of antidepressants, anxiolytics, and sedative-hypnotic drugs was higher in women, older people, and rural areas and lower in areas with social transformation needs, with these differences being statistically significant. Conclusions: The consumption of psychiatric drugs has increased over the COVID-19 pandemic, especially in women, older people, and rural areas. Thus, we should reflect on the adequate use of these drugs. |
format | Online Article Text |
id | pubmed-9030027 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-90300272022-04-23 Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic González-López, María del Carmen Díaz-Calvo, Virginia Ruíz-González, Carlos Nievas-Soriano, Bruno José Rebollo-Lavado, Belén Parrón-Carreño, Tesifón Int J Environ Res Public Health Article Background: The main objective of this research was to analyze whether there were changes in the use of antidepressants, anxiolytics, and hypnotic-sedative drugs, in the context of primary health care, during the COVID-19 pandemic compared to the pre-pandemic period. We further sought to study consumption in vulnerable population groups. Methods: A cross-sectional observational study was performed in a primary health district of Spain. The data were obtained from the Andalusian Public Health System database, for the pre-COVID-19 period, from March 2019 to February 2020, and for the COVID-19 period, from March 2020 to February 2021. Univariant and bivariant analyses were performed. The effect size was measured using the Rosenthal test. Results: While the total number of medical prescriptions decreased by 2.5% in the COVID-19 period, the prescriptions of psychiatric drugs increased by 6.1%. The increase in the dose consumption per 1000 inhabitants (DHD) was highest for anxiolytics (7.2%), followed by hypnotic-sedatives (5.6%) and antidepressants (3.7%). The consumption of antidepressants, anxiolytics, and sedative-hypnotic drugs was higher in women, older people, and rural areas and lower in areas with social transformation needs, with these differences being statistically significant. Conclusions: The consumption of psychiatric drugs has increased over the COVID-19 pandemic, especially in women, older people, and rural areas. Thus, we should reflect on the adequate use of these drugs. MDPI 2022-04-14 /pmc/articles/PMC9030027/ /pubmed/35457647 http://dx.doi.org/10.3390/ijerph19084782 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article González-López, María del Carmen Díaz-Calvo, Virginia Ruíz-González, Carlos Nievas-Soriano, Bruno José Rebollo-Lavado, Belén Parrón-Carreño, Tesifón Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic |
title | Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic |
title_full | Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic |
title_fullStr | Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic |
title_full_unstemmed | Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic |
title_short | Consumption of Psychiatric Drugs in Primary Care during the COVID-19 Pandemic |
title_sort | consumption of psychiatric drugs in primary care during the covid-19 pandemic |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030027/ https://www.ncbi.nlm.nih.gov/pubmed/35457647 http://dx.doi.org/10.3390/ijerph19084782 |
work_keys_str_mv | AT gonzalezlopezmariadelcarmen consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic AT diazcalvovirginia consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic AT ruizgonzalezcarlos consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic AT nievassorianobrunojose consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic AT rebollolavadobelen consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic AT parroncarrenotesifon consumptionofpsychiatricdrugsinprimarycareduringthecovid19pandemic |